SCHEMBL20113740

SCHEMBL20113740

COC(=O)c1[nH]c(Cl)nc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 4/20 0.39
KDM4C Q9H3R0 1/20 0.37
XDH P47989 1/20 0.34
CCNC P24863 1/20 0.34
CDK8 P49336 1/20 0.34
GAA P10253 4/20 0.33
MAPT P10636 3/20 0.33
CYP1A2 P05177 2/20 0.33
RECQL P46063 1/20 0.33
RHEB Q15382 1/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 4/20 0.33
HTT P42858 1/20 0.33
PADI4 Q9UM07 1/20 0.33
NR4A2 P43354 1/20 0.33
MMP2 P08253 1/20 0.32
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32
MMP13 P45452 1/20 0.32
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15050480 0.81 NPSR1 (0.41) NPSR1KDM4CXDHCCNCCDK8
SCHEMBL24284352 0.81 ALDH1A1 (0.47) MAPTCYP1A2RECQLALDH1A1KDM4E
SCHEMBL16210782 0.79 KDM4C (0.42) NPSR1KDM4CXDHCCNCCDK8
SCHEMBL24283742 0.78
SCHEMBL24283709 0.78 NPSR1 (0.39) NPSR1KDM4CXDHCCNCCDK8
SCHEMBL24283838 0.75 LMNA (0.37) NPSR1KDM4CXDHALDH1A1HPGD
SCHEMBL8710553 0.75 NPSR1 (0.36) NPSR1KDM4CXDHCCNCCDK8
SCHEMBL29544480 0.72 KDM4C (0.50) NPSR1KDM4CMAPTALDH1A1KDM4E
SCHEMBL20113741 0.72 MAPK14 (0.31) NPSR1KDM4CMAPK14
SCHEMBL24283685 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3360863-B1 ETOMIDATE DERIVATIVE AND INTERMEDIATE, PREPARATION METHOD AND USE THEREOF JIANGSU NHWALUOKANG PHARMACEUTICAL RES AND DEVELOPMENT CO LTD (CN) 2022-04-20 EP disclosed
EP-3009426-B1 4-ALKYNYL IMIDAZOLE DERIVATIVE AND MEDICINE COMPRISING SAME AS ACTIVE INGREDIENT KAKEN PHARMA CO LTD (JP) 2018-05-02 EP disclosed